| abstract |
Provided herein are fibroblast growth factor 19 (FGF19) protein and peptide sequence (and peptidomimetic) variants, and FGF19 and / or fibroblast growth factor 21 (FGF21) protein and Pharmaceutical compositions, formulations and dosage forms comprising fusions of peptide sequences (and peptidomimetics) and variants of fusions of protein and peptide sequences (and peptidomimetics) of FGF19 and / or FGF21. Also provided herein are methods of using the pharmaceutical compositions, formulations, and dosage forms. [Selection] Figure 1 |